TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive In Brief: Georgetown, Theurer Form Collaboration; Hopkins To Develop Bladder Cancer Institute June 6, 2014